Report
FREE
• Organto secured a €4M flexible financing and FX facility with Rabobank, improving liquidity and stabilizing currency exposure ahead of a key growth period for the business.
• Last week, OGO reported its Q3/25 results, in which revenue came in at $15.1M (+189% YoY) and EBITDA was ($0.7M).
• We recently re-initiated coverage on OGO and conducted an interview with CEO Steve Bromley; see the full report here and interview here.
This morning, Organto Foods (OGO:TSXV, OGOFF:OTC) announced that its European operations have secured a new integrated financing and foreign exchange solution with Rabobank, a leading Dutch cooperative bank with expertise in the agriculture and food sectors. The arrangement provides a €4M flexible working-capital facility tied to the Company’s qualified receivables, alongside expanded FX hedging capabilities through Rabobank’s Easy FX platform. Any funds borrowed will bear interest at the one-month EURIBOR rate plus a pre-established margin, in addition to an annual standby fee. The structure is designed to scale with Organto’s growth and offers immediate support as it enters a key contracting period for the business. The FX facility includes access to the Rabobank Easy FX platform and provides hedging at competitive rates without the need for immediate margin calls. We are maintaining our BUY rating and $1.00/share target price on OGO.
Today’s announcement comes after OGO reported its Q3/25 results last week (see our note here, and below for more details). Management attributed the negative EBITDA to losses on currency-hedging derivatives used to manage FX exposure, and we view today’s announcement as a direct step toward stabilizing and improving this aspect of the business. The added flexibility on the working capital side should also help smooth procurement cycles heading into the important contracting season, and we note that the facility includes the potential for expansion as OGO’s accounts receivable grow.
The need for the new facility signals further growth for Organto, strengthening its financial footing after a series of quarters of rapid growth, while also improving visibility into cashflow and supporting deep supplier relationships. We expect this to carry positive momentum into Q4 and the new year as the Company continues to execute on its growth plans and build on the progress made YTD. We remain bullish on OGO going into Q4; we are expecting $14.2M in revenue (+120% YoY) and EBITDA of $0.2M (1% margin) in Q4/25.
OGO: New Working Capital Facility Setting Up Future Growth
What you need to know:• Organto secured a €4M flexible financing and FX facility with Rabobank, improving liquidity and stabilizing currency exposure ahead of a key growth period for the business.
• Last week, OGO reported its Q3/25 results, in which revenue came in at $15.1M (+189% YoY) and EBITDA was ($0.7M).
• We recently re-initiated coverage on OGO and conducted an interview with CEO Steve Bromley; see the full report here and interview here.
This morning, Organto Foods (OGO:TSXV, OGOFF:OTC) announced that its European operations have secured a new integrated financing and foreign exchange solution with Rabobank, a leading Dutch cooperative bank with expertise in the agriculture and food sectors. The arrangement provides a €4M flexible working-capital facility tied to the Company’s qualified receivables, alongside expanded FX hedging capabilities through Rabobank’s Easy FX platform. Any funds borrowed will bear interest at the one-month EURIBOR rate plus a pre-established margin, in addition to an annual standby fee. The structure is designed to scale with Organto’s growth and offers immediate support as it enters a key contracting period for the business. The FX facility includes access to the Rabobank Easy FX platform and provides hedging at competitive rates without the need for immediate margin calls. We are maintaining our BUY rating and $1.00/share target price on OGO.
Today’s announcement comes after OGO reported its Q3/25 results last week (see our note here, and below for more details). Management attributed the negative EBITDA to losses on currency-hedging derivatives used to manage FX exposure, and we view today’s announcement as a direct step toward stabilizing and improving this aspect of the business. The added flexibility on the working capital side should also help smooth procurement cycles heading into the important contracting season, and we note that the facility includes the potential for expansion as OGO’s accounts receivable grow.
The need for the new facility signals further growth for Organto, strengthening its financial footing after a series of quarters of rapid growth, while also improving visibility into cashflow and supporting deep supplier relationships. We expect this to carry positive momentum into Q4 and the new year as the Company continues to execute on its growth plans and build on the progress made YTD. We remain bullish on OGO going into Q4; we are expecting $14.2M in revenue (+120% YoY) and EBITDA of $0.2M (1% margin) in Q4/25.
Underlying
Organto Foods Inc
Provider
Atrium Research Corporation
Atrium Research provides institutional quality issuer paid research on North American public equities using deep fundamental analysis. Our research reports are disseminated through Bloomberg, FactSet, Capital IQ, Reuters and many more, as well as through our social media and email distribution lists.
Nicholas Cortellucci, CFA
Other Reports on these Companies
Other Reports from Atrium Research Corporation
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.